Improving Clinic Delivery of HIV-related Anal Health Services

NCT07464236 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-03-18

No results posted yet for this study

Summary

This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI) testing, preventive medications, and cancer screening. By evaluating these stigma-reduction strategies in eight clinics in the Mississippi Delta, a region with high rates of HIV and STIs, the research team will learn whether and how these approaches work to improve access to care. The results will help guide healthcare systems in using the most effective methods to reduce stigma, making it easier for people to get prevention services and improving public health.

Conditions

  • HIV
  • Gonorrhea
  • Chlamydia
  • Anal Cancer Squamous Cell

Interventions

BEHAVIORAL

PEACHES 2.0 Implementation Strategies

PEACHES 2.0 is a set of training and quality improvement implementation strategies to increase provider adoption and patient uptake of evidence-based anal sex-related HIV interventions: anorectal STI screening, Doxy-PEP, PrEP, and anal cancer screening.

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER
  • Denver Prevention Training Center

    collaborator UNKNOWN
  • Coastal Family Health Center

    collaborator UNKNOWN
  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Bryan Kutner, PhD, MPH · Albert Einstein College of Medicine

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2030-04-30
Completion
2030-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07464236 on ClinicalTrials.gov